| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | -0.0057 | 0.9 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | -0.0058 | 0.9 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | 0.006 | 0.9 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.0072 | 0.9 |
| mRNA | shikonin | GDSC1000 | pan-cancer | AAC | -0.0053 | 0.9 |
| mRNA | skepinone-L | CTRPv2 | pan-cancer | AAC | 0.0079 | 0.9 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | 0.0057 | 0.9 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | 0.0087 | 0.9 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | 0.0048 | 0.9 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | -0.0057 | 0.9 |